NF-kappaB regulates the expression of the human complement receptor 2 gene

Area of Science:

• Immunology
• Molecular Biology
• Gene Regulation

Background:

• Complement receptor 2 (CR2) is crucial for regulating B cell responses to antigens.
• Understanding the transcriptional regulation of CR2 is essential for deciphering B cell activation mechanisms.

Purpose of the Study:

• To investigate the role of Nuclear Factor-kappa B (NF-κB) in regulating the expression of the human CR2 gene.
• To identify specific promoter elements and transcription factors involved in NF-κB-mediated CR2 gene activation.

Main Methods:

• Promoter truncation, deletion, and mutagenesis analyses were performed on the human CR2 gene promoter.
• Electrophoretic mobility shift assays (EMSA) and supershift analyses were used to identify DNA-binding proteins.
• Chromatin immunoprecipitation (ChIP) assays were conducted to confirm in vivo binding of NF-κB proteins to the CR2 promoter.
• Functional assays in B cell lines and primary B cells assessed promoter activity under various conditions, including stimulation with lipopolysaccharide (LPS).

Main Results:

• NF-κB signaling enhances the expression of the human CR2 gene.
• Specific NF-κB binding sites and an overlapping X box/E box within the CR2 promoter were identified as critical for this regulation.
• NF-κB proteins (p50, p65, c-Rel) were shown to bind to these elements in vitro and in vivo.
• Stimulation of NF-κB pathways, including LPS treatment, led to increased CR2 promoter activity and surface CR2 protein expression on B cells.

Conclusions:

• The NF-κB signaling pathway directly enhances CR2 gene expression through binding to specific promoter elements.
• Increased CR2 expression on B cells, mediated by NF-κB, may play a role in sensitizing B cells to antigen stimulation at the onset of infection.
• This mechanism highlights a novel regulatory pathway for CR2, impacting adaptive immune responses.